FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIVBusiness Wire • 05/16/22
Why the 5 Highest-Yielding Nasdaq Stocks May Be the Best and Safest Value Buys Now24/7 Wall Street • 05/03/22
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and InflammationBusiness Wire • 05/02/22
Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/29/22
How Gilead is positioning its COVID-19 drug against newer antivirals like PaxlovidMarket Watch • 04/27/22
Veklury® (Remdesivir) is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19Business Wire • 04/25/22